These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

767 related articles for article (PubMed ID: 9862768)

  • 1. Modulation of the permeability of H2 receptor antagonists cimetidine and ranitidine by P-glycoprotein in rat intestine and the human colonic cell line Caco-2.
    Collett A; Higgs NB; Sims E; Rowland M; Warhurst G
    J Pharmacol Exp Ther; 1999 Jan; 288(1):171-8. PubMed ID: 9862768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
    Dahan A; Amidon GL
    Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transport of rhodamine 123, a P-glycoprotein substrate, across rat intestine and Caco-2 cell monolayers in the presence of cytochrome P-450 3A-related compounds.
    Yumoto R; Murakami T; Nakamoto Y; Hasegawa R; Nagai J; Takano M
    J Pharmacol Exp Ther; 1999 Apr; 289(1):149-55. PubMed ID: 10086998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonlinear absorption of methylprednisolone by absorptive and secretory transporters.
    Tomita M; Watanabe A; Fujinaga I; Yamakawa T; Hayashi M
    Int J Pharm; 2010 Mar; 387(1-2):1-6. PubMed ID: 19883743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal absorptive transport of the hydrophilic cation ranitidine: a kinetic modeling approach to elucidate the role of uptake and efflux transporters and paracellular vs. transcellular transport in Caco-2 cells.
    Bourdet DL; Pollack GM; Thakker DR
    Pharm Res; 2006 Jun; 23(6):1178-87. PubMed ID: 16741656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Permeability dominates in vivo intestinal absorption of P-gp substrate with high solubility and high permeability.
    Cao X; Yu LX; Barbaciru C; Landowski CP; Shin HC; Gibbs S; Miller HA; Amidon GL; Sun D
    Mol Pharm; 2005; 2(4):329-40. PubMed ID: 16053336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of HT29-18-C1 and Caco-2 cell lines as models for studying intestinal paracellular drug absorption.
    Collett A; Sims E; Walker D; He YL; Ayrton J; Rowland M; Warhurst G
    Pharm Res; 1996 Feb; 13(2):216-21. PubMed ID: 8932439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polarized efflux of mono- and diacid metabolites of ME3229, an ester-type prodrug of a glycoprotein IIb/IIIa receptor antagonist, in rat small intestine.
    Okudaira N; Komiya I; Sugiyama Y
    J Pharmacol Exp Ther; 2000 Nov; 295(2):717-23. PubMed ID: 11046110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saturable absorptive transport of the hydrophilic organic cation ranitidine in Caco-2 cells: role of pH-dependent organic cation uptake system and P-glycoprotein.
    Bourdet DL; Thakker DR
    Pharm Res; 2006 Jun; 23(6):1165-77. PubMed ID: 16741655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cimetidine absorption and elimination in rat small intestine.
    Piyapolrungroj N; Zhou YS; Li C; Liu G; Zimmermann E; Fleisher D
    Drug Metab Dispos; 2000 Jan; 28(1):65-72. PubMed ID: 10611142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic profiling of P-glycoprotein-mediated drug efflux in rat and human intestinal epithelia.
    Stephens RH; O'Neill CA; Warhurst A; Carlson GL; Rowland M; Warhurst G
    J Pharmacol Exp Ther; 2001 Feb; 296(2):584-91. PubMed ID: 11160647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new approach to predict human intestinal absorption using porcine intestinal tissue and biorelevant matrices.
    Westerhout J; van de Steeg E; Grossouw D; Zeijdner EE; Krul CA; Verwei M; Wortelboer HM
    Eur J Pharm Sci; 2014 Oct; 63():167-77. PubMed ID: 25046168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of intestinal absorption enhancement and local mucosal toxicity of two promoters. I. Studies in isolated rat and human colonic mucosae.
    Maher S; Kennelly R; Bzik VA; Baird AW; Wang X; Winter D; Brayden DJ
    Eur J Pharm Sci; 2009 Nov; 38(4):291-300. PubMed ID: 19737613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport.
    Hilgendorf C; Spahn-Langguth H; Regårdh CG; Lipka E; Amidon GL; Langguth P
    J Pharm Sci; 2000 Jan; 89(1):63-75. PubMed ID: 10664539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereoselective and multiple carrier-mediated transport of cetirizine across Caco-2 cell monolayers with potential drug interaction.
    He Y; Liu Y; Zeng S
    Chirality; 2010 Jul; 22(7):684-92. PubMed ID: 20014242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of binding properties to human P-glycoprotein: development of a [3H]verapamil radioligand-binding assay.
    Döppenschmitt S; Langguth P; Regårdh CG; Andersson TB; Hilgendorf C; Spahn-Langguth H
    J Pharmacol Exp Ther; 1999 Jan; 288(1):348-57. PubMed ID: 9862789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulating effect of polyethylene glycol on the intestinal transport and absorption of prednisolone, methylprednisolone and quinidine in rats by in-vitro and in-situ absorption studies.
    Shen Q; Li W; Lin Y; Katsumi H; Okada N; Sakane T; Fujita T; Yamamoto A
    J Pharm Pharmacol; 2008 Dec; 60(12):1633-41. PubMed ID: 19000368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-treatment with grapefruit juice inhibits while chronic administration activates intestinal P-glycoprotein-mediated drug efflux.
    Panchagnula R; Bansal T; Varma MV; Kaul CL
    Pharmazie; 2005 Dec; 60(12):922-7. PubMed ID: 16398269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional role of P-glycoprotein in limiting intestinal absorption of drugs: contribution of passive permeability to P-glycoprotein mediated efflux transport.
    Varma MV; Sateesh K; Panchagnula R
    Mol Pharm; 2005; 2(1):12-21. PubMed ID: 15804173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescein transport properties across artificial lipid membranes, Caco-2 cell monolayers and rat jejunum.
    Berginc K; Zakelj S; Levstik L; Ursic D; Kristl A
    Eur J Pharm Biopharm; 2007 May; 66(2):281-5. PubMed ID: 17129714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.